# Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings

> **NCT06561958** · — · ACTIVE_NOT_RECRUITING · sponsor: **Ferring Pharmaceuticals** · enrollment: 1500 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** REKOVELLE

## Key facts

- **NCT ID:** NCT06561958
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-27
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06561958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06561958, "Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06561958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*